Differences in clinical characteristics and cardiovascular disease risk prediction among Chinese women with polycystic ovary syndrome phenotypes: a cross-sectional study - Summary - MDSpire
Advertisement
Differences in clinical characteristics and cardiovascular disease risk prediction among Chinese women with polycystic ovary syndrome phenotypes: a cross-sectional study
To characterize clinical profiles of PCOS phenotypes, predict specific cardiovascular disease (CVD) risks, and evaluate associations between phenotypes and CVD risk in Chinese women.
Key Findings:
Phenotypes A, B, and C had significantly higher BMI, WC, SBP, DBP, UA, LDL-C, TG, and HOMA-IR compared to phenotype D, indicating worse metabolic profiles.
Lifetime CVD risk scores were significantly higher in phenotypes A, B, and C (15.55%, 17.65%, 17.30%) compared to D (9.90%), suggesting a need for targeted interventions.
Phenotypes A, B, and C were significantly associated with higher odds of high lifetime CVD risk compared to D after adjustments, highlighting the importance of phenotype-specific assessments.
Interpretation:
Women with phenotypes A, B, and C exhibit more adverse clinical profiles and higher CVD risk, with BMI, HOMA-IR, and UA identified as mediators in this relationship.
Limitations:
The study is cross-sectional, limiting causal inferences and temporal relationships.
Sample size may not fully represent the broader population of women with PCOS, potentially affecting generalizability.
Potential biases in data collection or analysis may influence results.
Conclusion:
Regular CVD risk assessments are recommended for women with different PCOS phenotypes to guide individualized treatment strategies, particularly focusing on weight and metabolic management.
